NUVALENT INC's ticker is and the CUSIP is 670703107. A total of 50 filers reported holding NUVALENT INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $57,943,622 | +17.6% | 1,260,466 | +7.9% | 0.00% | 0.0% |
| Q2 2023 | $49,254,096 | +81.0% | 1,167,989 | +12.0% | 0.00% | +50.0% |
| Q1 2023 | $27,217,166 | -45.1% | 1,043,203 | -37.4% | 0.00% | +100.0% |
| Q4 2022 | $49,616,338 | +766.2% | 1,666,096 | +465.5% | 0.00% | – |
| Q3 2022 | $5,728,000 | +48.5% | 294,632 | +3.6% | 0.00% | – |
| Q2 2022 | $3,856,000 | +22.6% | 284,359 | +25.6% | 0.00% | – |
| Q1 2022 | $3,145,000 | -1.9% | 226,439 | +34.4% | 0.00% | – |
| Q4 2021 | $3,207,000 | +2.4% | 168,453 | +21.3% | 0.00% | – |
| Q3 2021 | $3,132,000 | – | 138,911 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 19,341,024 | $436,140,000 | 8.51% |
| Fairmount Funds Management LLC | 914,614 | $20,625,000 | 7.50% |
| Bain Capital Life Sciences Investors, LLC | 3,428,014 | $77,302,000 | 4.80% |
| VR Adviser, LLC | 803,951 | $18,129,000 | 2.33% |
| Boxer Capital, LLC | 1,210,192 | $27,290,000 | 0.95% |
| BVF INC/IL | 448,512 | $10,114,000 | 0.40% |
| Avoro Capital Advisors LLC | 1,257,671 | $22,288,000 | 0.35% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,052,394 | $23,731,000 | 0.28% |
| Perceptive Advisors | 750,000 | $16,913,000 | 0.25% |
| Logos Global Management LP | 134,650 | $2,733,000 | 0.20% |